{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T20:32:08Z","timestamp":1724877128511},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,1]]},"DOI":"10.7759\/cureus.51490","type":"journal-article","created":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T05:40:50Z","timestamp":1704174050000},"source":"Crossref","is-referenced-by-count":1,"title":["Pyoderma Gangrenosum: The Impact of Treatment Non-adherence on Disease Progression"],"prefix":"10.7759","author":[{"given":"Carmen","family":"Iliescu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liliana","family":"Popa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mara","family":"Mihai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marius N","family":"Popescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Beiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03199.x","article-title":"Pyoderma gangrenosum: an updated review","volume":"23","author":"Ruocco E","year":"2009","unstructured":"Ruocco E, Sangiuliano S, Gravina AG, Miranda A, Nicoletti G. Pyoderma gangrenosum: an updated review. J Eur Acad Dermatol Venereol. 2009, 23:1008-17. 10.1111\/j.1468-3083.2009.03199.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10565.x","article-title":"Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients","volume":"165","author":"Binus AM","year":"2011","unstructured":"Binus AM, Qureshi AA, Li VW, Winterfield LS. Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients. Br J Dermatol. 2011, 165:1244-50. 10.1111\/j.1365-2133.2011.10565.x","journal-title":"Br J Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.19-3-224","article-title":"Pyoderma gangrenosum - a guide to diagnosis and management","volume":"19","author":"George C","year":"2019","unstructured":"George C, Deroide F, Rustin M. Pyoderma gangrenosum - a guide to diagnosis and management\u2002. Clin Med (Lond). 2019, 19:224-8. 10.7861\/clinmedicine.19-3-224","journal-title":"Clin Med (Lond)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2017.5980","article-title":"Diagnostic criteria of ulcerative pyoderma gangrenosum: a Delphi consensus of international experts","volume":"154","author":"Maverakis E","year":"2018","unstructured":"Maverakis E, Ma C, Shinkai K, et al.. Diagnostic criteria of ulcerative pyoderma gangrenosum: a Delphi consensus of international experts. JAMA Dermatol. 2018, 154:461-6. 10.1001\/jamadermatol.2017.5980","journal-title":"JAMA Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2165\/11595240-000000000-00000","article-title":"Etiology and management of pyoderma gangrenosum: a comprehensive review","volume":"13","author":"Ahronowitz I","year":"2012","unstructured":"Ahronowitz I, Harp J, Shinkai K. Etiology and management of pyoderma gangrenosum: a comprehensive review. Am J Clin Dermatol. 2012, 13:191-211. 10.2165\/11595240-000000000-00000","journal-title":"Am J Clin Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2310\/7750.2009.00002","article-title":"Pyoderma gangrenosum: common pitfalls in management and a stepwise, evidence-based, therapeutic approach","volume":"13 Suppl 1","author":"Prajapati V","year":"2009","unstructured":"Prajapati V, Man J, Brassard A. Pyoderma gangrenosum: common pitfalls in management and a stepwise, evidence-based, therapeutic approach. J Cutan Med Surg. 2009, 13 Suppl 1:S2-11. 10.2310\/7750.2009.00002","journal-title":"J Cutan Med Surg"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.074815","article-title":"Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial","volume":"55","author":"Brooklyn TN","year":"2006","unstructured":"Brooklyn TN, Dunnill MG, Shetty A, et al.. Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial. Gut. 2006, 55:505-9. 10.1136\/gut.2005.074815","journal-title":"Gut"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-0960.2011.00750.x","article-title":"Pyoderma gangrenosum requiring inpatient management: a report of 26 cases with follow up","volume":"52","author":"Saracino A","year":"2011","unstructured":"Saracino A, Kelly R, Liew D, Chong A. Pyoderma gangrenosum requiring inpatient management: a report of 26 cases with follow up. Australas J Dermatol. 2011, 52:218-21. 10.1111\/j.1440-0960.2011.00750.x","journal-title":"Australas J Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15061606","article-title":"Antimicrobial biomaterials for chronic wound care","volume":"15","author":"Miron A","year":"2023","unstructured":"Miron A, Giurcaneanu C, Mihai MM, et al.. Antimicrobial biomaterials for chronic wound care. Pharmaceutics. 2023, 15:10.3390\/pharmaceutics15061606","journal-title":"Pharmaceutics"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1046\/j.1524-4725.2000.0260111063.x","article-title":"Surgical management of pyoderma gangrenosum: case report and review","volume":"26","author":"Alam M","year":"2000","unstructured":"Alam M, Grossman ME, Schneiderman PI, Blume RS, Benvenisty AI. Surgical management of pyoderma gangrenosum: case report and review. Dermatol Surg. 2000, 26:1063-6. 10.1046\/j.1524-4725.2000.0260111063.x","journal-title":"Dermatol Surg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/218799-pyoderma-gangrenosum-the-impact-of-treatment-non-adherence-on-disease-progression","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:12:31Z","timestamp":1707509551000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/218799-pyoderma-gangrenosum-the-impact-of-treatment-non-adherence-on-disease-progression"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,1]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.51490","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,1]]}}}